On September 10, Deutsche Post AG, trading as DHL Group, announced its second acquisition of the year with the purchase of SDS Rx. The financial terms were not disclosed.
Based in Tampa, Florida, SDS Rx provides specialized healthcare deliveries from more than 200 locations across the country.
DHL Group is a German multinational package delivery and supply chain management company. It specializes in technology, life sciences and healthcare, engineering, manufacturing and energy, auto-mobility and retail services.
Previously in 2025, DHL Group purchased CRYOPDP, a courier service provider for clinical trials, biopharmaceuticals and cell and gene therapies. CRYOPDP operates in 15 countries and handles more than 600,000 shipments annually across more than 135 countries.
According to data captured in the LevinPro HC database, this transaction marks the 22nd healthcare product distributor transaction of the year. This outpaces the deal volume of 2024, when 29 healthcare product distributor transactions were reported for the entire year.
